Resmed inc.RMD.US Overview

• When is RMD's latest earnings report released?

  The most recent financial report for Resmed inc. (RMD) covers the period of 2026Q2 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating RMD's short-term business performance and financial health. For the latest updates on RMD's earnings releases, visit this page regularly.

• Where does RMD fall in the P/E River chart?

  According to historical valuation range analysis, Resmed inc. (RMD)'s current price-to-earnings (P/E) ratio is 25.33, placing it in the Undervalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

• What is the operating profit of RMD?

  According to the latest financial report, Resmed inc. (RMD) reported an Operating Profit of 491.66M with an Operating Margin of 34.56% this period, representing a growth of 17.84% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

• How is RMD's revenue growth?

  In the latest financial report, Resmed inc. (RMD) announced revenue of 1.42B, with a Year-Over-Year growth rate of 10.98%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

• How much debt does RMD have?

  As of the end of the reporting period, Resmed inc. (RMD) had total debt of 847.72M, with a debt ratio of 0.1. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

• How much cash does RMD have?

  At the end of the period, Resmed inc. (RMD) held Total Cash and Cash Equivalents of 1.42B, accounting for 0.17 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

• Does RMD go with three margins increasing?

  In the latest report, Resmed inc. (RMD) achieved the “three margins increasing” benchmark, with a gross margin of 61.8%%, operating margin of 34.56%%, and net margin of 27.6%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess RMD's profit trajectory and future growth potential.

• Is RMD's EPS continuing to grow?

  According to the past four quarterly reports, Resmed inc. (RMD)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 2.69. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

• What is the FCF of RMD?

  Resmed inc. (RMD)'s Free Cash Flow (FCF) for the period is 311.21M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 8.07% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

• What are the PEG ratio and PE ratio of RMD?

  The latest valuation data shows Resmed inc. (RMD) has a Price-To-Earnings (PE) ratio of 25.33 and a Price/Earnings-To-Growth (PEG) ratio of 1.72. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.

RMD Earnings Table